Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|15|6|448-455

ISSN： 1570-162X

Source： Current HIV Research, Vol.15, Iss.6, 2018-01, pp. : 448-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

By Campo R. DeJesus E. Bredeek U. F. Henry K. Khanlou H. Logue K. Brinson C. Benson P. Dau L. Wang H. White K. Flaherty J. Fralich T. Guyer B. Piontkowsky D.

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1637-1645

Oxford University Press

Access to resources Recommend Favorite

Switching to Raltegravir in Virologically Suppressed in HIV-1-Infected Patients: A Retrospective, Multicenter, Descriptive Study

Current HIV Research, Vol. 10, Iss. 8, 2012-01 ,pp. : 673-678

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Residual Viremia and Proviral DNA in Patients with Suppressed Plasma Viral Load (<400 HIV-RNA cp/ml) During Different Antiretroviral Regimens

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 261-266

Bentham Science Publishers

Access to resources Recommend Favorite

Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens

Current HIV Research, Vol. 6, Iss. 1, 2008-01 ,pp. : 70-76

Bentham Science Publishers

Access to resources Recommend Favorite

Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients

Current HIV Research, Vol. 14, Iss. 4, 2016-06 ,pp. : 331-339

Bentham Science Publishers

Access to resources Recommend Favorite